Health
Pig heart transplanted into human patient for the second time
Surgeons have transplanted a pig’s heart into a dying man in a bid to prolong his life – only the second patient to ever undergo such an experimental feat. Two days later, the man was cracking jokes and able to sit in a chair, Maryland doctors said Friday.
The 58-year-old Navy veteran was facing near-certain death from heart failure but other health problems meant he wasn’t eligible for a traditional heart transplant, according to doctors at University of Maryland Medicine, the Associated Press reported.
“Nobody knows from this point forward. At least now I have hope and I have a chance,” Lawrence Faucette, from Frederick, Maryland, said in a video recorded by the hospital before Wednesday’s operation. “I will fight tooth and nail for every breath I can take.”
While the next few weeks will be critical, doctors were thrilled at Faucette’s early response to the pig organ.
“You know, I just keep shaking my head – how am I talking to someone who has a pig heart?” Dr. Bartley Griffith, who performed the transplant, told The Associated Press. He said doctors are feeling “a great privilege but, you know, a lot of pressure.”
The same Maryland team last year performed the world’s first transplanet of a genetically modified pig heart into another dying man, David Bennett, who survived just two months.
There’s a huge shortage of human organs donated for transplant. Last year, there were just over 4,100 heart transplants in the U.S., a record number but the supply is so tight that only patients with the best chance of long-term survival get offered one.
Attempts at animal-to-human organ transplants have failed for decades, as people’s immune systems immediately destroyed the foreign tissue. Now scientists are trying again using pigs genetically modified to make their organs more humanlike.
Recently, scientists at other hospitals have tested pig kidneys and hearts in donated human bodies, hoping to learn enough to begin formal studies of what are called xenotransplants.
To make this new attempt in a living patient outside of a rigorous trial, the Maryland researchers required special permission from the Food and Drug Administration, under a process reserved for certain emergency cases with no other options.
It took over 300 pages of documents filed with FDA, but the Maryland researchers made their case that they’d learned enough from their first attempt last year – even though that patient died for reasons that aren’t fully understood – that it made sense to try again.
And Faucette, who retired as a lab technician at the National Institutes of Health, had to agree that he understood the procedure’s risks.
In a statement his wife, Ann Faucette, said: “We have no expectations other than hoping for more time together. That could be as simple as sitting on the front porch and having coffee together.”
What’s different this time: Only after last year’s transplant did scientists discover signs of a pig virus lurking inside the heart – and they now have better tests to look for hidden viruses. They also made some medication changes.
Possibly more important, while Faucette has end-stage heart failure and was out of other options, he wasn’t as near death as the prior patient.
By Friday, his new heart was functioning well without any supportive machinery, the hospital said.
“It’s just an amazing feeling to see this pig heart work in a human,” said Dr. Muhammad Mohiuddin, the Maryland team’s xenotransplantation expert. But, he cautioned, “we don’t want to predict anything. We will take every day as a victory and move forward.”
This kind of single-patient “compassionate use” can provide some information about how the pig organ works but not nearly as much as more formal testing, said Karen Maschke, a research scholar at the Hastings Center who is helping develop ethics and policy recommendations for xenotransplant clinical trials. That FDA allowed this second case “suggests that the agency is not ready to permit a pig heart clinical trial to start,” Mashke added.
The pig heart, provided by Blacksburg, Virginia-based Revivicor, has 10 genetic modifications – knocking out some pig genes and adding some human ones to make it more acceptable to the human immune system.
Health
Afghan Health Minister hails India visit as new chapter in bilateral ties
Afghanistan’s Minister of Public Health, Noor Jalal Jalali, has described his recent visit to India as an important new chapter in strengthening health cooperation between Kabul and New Delhi.
Speaking at a press conference in Kabul on Tuesday, Jalali said the trip focused on expanding bilateral health collaboration and addressing key challenges facing Afghanistan’s healthcare system. He outlined the main objectives of the visit as preventing potential medicine shortages, standardizing traditional medicine, importing high-quality and affordable medicines, building the capacity of health workers through training programs, facilitating medical treatment for Afghan patients in India, and developing professional expertise in traditional medicine.
Jalali said India and relevant institutions made several concrete commitments during the visit. These include the provision of vaccines worth $5 million, a radiotherapy machine for cancer treatment valued at $3 million, five tons of cancer medicines worth $1 million, a CT scan machine valued at $300,000, and support for the construction of a hospital and a specialized thalassemia treatment center valued at $500,000.
According to a statement from the Ministry of Public Health, the visit also resulted in agreements on capacity-building programs for specialists and healthcare workers, the donation of 70,000 medical ampoules by an Afghan investor, plans to establish a research center and an institute of traditional medicine in Kabul, the transfer of high-quality medicines to Afghanistan, meeting market needs, and increased investment in the health sector.
The ministry said these outcomes represent significant progress in enhancing healthcare services and long-term cooperation between Afghanistan and India.
Health
Afghan health minister hails India’s support, calls medical visas vital for patients
Jalali said India is planning to build a 30-bed hospital in Kabul’s Bagrami district, which is expected to include an oncology center, a trauma unit, and maternal and child healthcare clinics.
Afghanistan’s Minister of Public Health, Noor Jalal Jalali, has praised India’s long-standing support for Afghanistan’s healthcare sector, describing Indian medical visas as a “vital humanitarian channel” for Afghan patients.
In an interview with an Indian television network, during his official visit to New Delhi, Jalali said Afghans have long relied on India for medical treatment, noting that the facilitation of medical visas has enabled thousands of patients to access advanced healthcare services in recent years.
He welcomed India’s contributions to Afghanistan’s health infrastructure, highlighting the Indira Gandhi Institute of Child Health in Kabul as one of the country’s most important pediatric hospitals.
India has supported the facility through the establishment of a thalassemia center, a modern diagnostic unit, upgrades to heating systems, and plans to provide a CT scan machine.
Jalali said India is also planning to build a 30-bed hospital in Kabul’s Bagrami district, which is expected to include an oncology center, a trauma unit, and maternal and child healthcare clinics.
He added that India has fitted around 75 Afghan patients with prosthetic limbs under the Jaipur Foot program and donated 20 ambulances.
During talks with India’s Minister of Health and Family Welfare, Jalali called for expanded cooperation in medical equipment, pharmaceutical regulation, training of healthcare workers, and the supply of essential medicines, particularly cancer drugs. He said India has pledged to provide these medicines on an urgent basis.
The Afghan health minister stressed the importance of capacity building, including training Afghan doctors in India and deploying Indian medical teams to Afghanistan.
He also said agreements have been reached to cooperate in traditional medicine, including Ayurveda and Unani practices, with plans to establish a Traditional Medicine Institute and Research Center in Afghanistan.
Jalali noted that Afghanistan has diversified its pharmaceutical import routes to ensure a steady supply of medicines and address concerns over counterfeit and substandard drugs through stronger regulation.
He described Afghanistan–India relations as people-centric and rooted in humanitarian values, expressing hope that cooperation in healthcare, pharmaceuticals, and medical infrastructure will continue to deepen.
Health
Afghan health officials visit Indian medical institute to expand ties
India has historically been a key partner in Afghanistan’s health and education sectors, providing training, medical support and institutional cooperation.
During an official visit to India, a technical delegation from Afghanistan’s Ministry of Public Health visited the Hamdard Institute of Medical Sciences and Research (HIMSR) in New Delhi, as part of efforts to strengthen cooperation in the health sector, particularly in the field of traditional medicine.
Officials and senior professors at HIMSR welcomed the Afghan team and provided detailed briefings on the institution’s academic programmes, research activities and medical services.
Discussions focused on opportunities for closer collaboration in traditional and integrative medicine, an area where Hamdard has long-standing expertise and international recognition.
HIMSR’s leadership expressed readiness to work with Afghan health authorities on joint research initiatives, quality testing and standardisation of traditional medicines through Hamdard’s laboratories, as well as knowledge-sharing programmes. The institution also pledged to offer scholarships and specialised training opportunities for Afghan doctors and medical professionals.
The visit comes as Afghanistan seeks to rebuild and strengthen its public health system amid ongoing economic and humanitarian challenges, with an emphasis on cost-effective and culturally accepted healthcare approaches such as traditional medicine.
India has historically been a key partner in Afghanistan’s health and education sectors, providing training, medical support and institutional cooperation.
Both sides said enhanced collaboration would contribute to improving public health outcomes, standardising traditional medicine practices, and expanding scientific and medical institutions in Afghanistan.
They reaffirmed their commitment to developing the partnership in a sustainable manner, aimed at long-term capacity building and mutual benefit.
-
Latest News2 days agoAfghanistan signs 30-year deal for marble mining in Daikundi
-
Latest News4 days agoAfghan border forces prevent illegal entry of hundreds into Iran
-
Latest News4 days agoPakistan summons Afghan diplomat over deadly attack in North Waziristan
-
Latest News3 days agoAfghan health minister calls for medical cooperation between Kabul and New Delhi
-
Latest News4 days agoJapan allocates nearly $20 million in humanitarian aid for Afghanistan
-
Latest News4 days agoKarzai urges reopening of girls’ schools and universities for Afghanistan’s bright future
-
Latest News3 days agoBush Institute criticizes Trump administration’s Afghan immigration freeze
-
Health5 days agoIndia issues over 200 medical visas to Afghans in last four months
